These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31285517)

  • 1. A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer's Disease.
    Gibbs E; Silverman JM; Zhao B; Peng X; Wang J; Wellington CL; Mackenzie IR; Plotkin SS; Kaplan JM; Cashman NR
    Sci Rep; 2019 Jul; 9(1):9870. PubMed ID: 31285517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA).
    Pradier L; Blanchard-Brégeon V; Bohme A; Debeir T; Menager J; Benoit P; Barneoud P; Taupin V; Bertrand P; Dugay P; Cameron B; Shi Y; Naimi S; Duchesne M; Gagnaire M; Weeden T; Travaline T; Reczek D; Khiroug L; Slaoui M; Brunel P; Fukuyama H; Ravetch J; Canton T; Cohen C
    Alzheimers Res Ther; 2018 Nov; 10(1):117. PubMed ID: 30486882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-PrP
    Cox TO; Gunther EC; Brody AH; Chiasseu MT; Stoner A; Smith LM; Haas LT; Hammersley J; Rees G; Dosanjh B; Groves M; Gardener M; Dobson C; Vaughan T; Chessell I; Billinton A; Strittmatter SM
    Ann Clin Transl Neurol; 2019 Mar; 6(3):554-574. PubMed ID: 30911579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta.
    Wang J; Hara H; Makifuchi T; Tabira T
    J Alzheimers Dis; 2008 Jun; 14(2):161-73. PubMed ID: 18560128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.
    Silverman JM; Gibbs E; Peng X; Martens KM; Balducci C; Wang J; Yousefi M; Cowan CM; Lamour G; Louadi S; Ban Y; Robert J; Stukas S; Forloni G; Hsiung GR; Plotkin SS; Wellington CL; Cashman NR
    ACS Chem Neurosci; 2018 Jul; 9(7):1591-1606. PubMed ID: 29614860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.
    Yang T; Hong S; O'Malley T; Sperling RA; Walsh DM; Selkoe DJ
    Alzheimers Dement; 2013 Mar; 9(2):99-112. PubMed ID: 23375565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
    Tucker S; Möller C; Tegerstedt K; Lord A; Laudon H; Sjödahl J; Söderberg L; Spens E; Sahlin C; Waara ER; Satlin A; Gellerfors P; Osswald G; Lannfelt L
    J Alzheimers Dis; 2015; 43(2):575-88. PubMed ID: 25096615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer's Disease.
    Vander Zanden CM; Chi EY
    J Pharm Sci; 2020 Jan; 109(1):68-73. PubMed ID: 31647950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.
    Venkataramani V; Wirths O; Budka H; Härtig W; Kovacs GG; Bayer TA
    J Alzheimers Dis; 2012; 29(2):361-71. PubMed ID: 22232007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.
    Canovi M; Markoutsa E; Lazar AN; Pampalakis G; Clemente C; Re F; Sesana S; Masserini M; Salmona M; Duyckaerts C; Flores O; Gobbi M; Antimisiaris SG
    Biomaterials; 2011 Aug; 32(23):5489-97. PubMed ID: 21529932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective neutralization of APP-C99 with monoclonal antibodies reduces the production of Alzheimer's Aβ peptides.
    Houacine J; Bolmont T; Aeschbach L; Oulad-Abdelghani M; Fraering PC
    Neurobiol Aging; 2012 Nov; 33(11):2704-14. PubMed ID: 22317957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Pathological Amyloid Aggregates with Conformation-Sensitive Antibodies.
    Bigi A; Loffredo G; Cascella R; Cecchi C
    Curr Alzheimer Res; 2020; 17(8):722-734. PubMed ID: 33167834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and network mechanisms underlying memory impairment induced by amyloid β protein.
    Salgado-Puga K; Pena-Ortega F
    Protein Pept Lett; 2015; 22(4):303-21. PubMed ID: 25642991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.
    Liu J; Yang B; Ke J; Li W; Suen WC
    Drugs Aging; 2016 Oct; 33(10):685-697. PubMed ID: 27699633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: a stochastic modelling approach.
    Proctor CJ; Pienaar IS; Elson JL; Kirkwood TB
    Mol Neurodegener; 2012 Jul; 7():32. PubMed ID: 22748062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
    Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
    Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.